Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Smadja

Showing results (91-100 of 225) with videos related to

Pageof 23
Sort By:
Annales De Biologie Clinique|September 6, 2024
[Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance]Corentin S Lefebvre, Sophie Luneau, Nûn Kalim Bentounes, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
The First Autoregulated Total Artificial Heart Implant in the United StatesJacob N Schroder, Sharon L McCartney, Piet Jansen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 17, 2022
Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantationDavid M Smadja, Peter Ivak, Yuri Pya, et al.
Angiogenesis|December 20, 2024
Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19David M Smadja, Sven Günther, Pauline Cavagna, et al.
Leukemia|September 18, 2023
Correction: Human CD34<sup>+</sup> very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acidAlison Domingues, Elisa Rossi, Kamila Bujko, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 8, 2017
A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot studyChristian Latrémouille, Alain Carpentier, Pascal Leprince, et al.
Stem Cell Reviews and Reports|March 14, 2025
Circulating CD34<sup>+</sup> Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary EmbolismNicolas Gendron, Benjamin Planquette, Anne Roche, et al.
Oncoimmunology|December 21, 2020
No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, et al.
Leukemia|February 16, 2022
Human CD34<sup>+</sup> very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acidAlison Domingues, Elisa Rossi, Kamila Bujko, et al.
Angiogenesis|May 11, 2021
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalanceAurélien Philippe, Nicolas Gendron, Olivier Bory, et al.
Pageof 23

Showing results (91-100 of 225) with videos related to

Sort By:
Pageof 23
Annales De Biologie Clinique|September 6, 2024
[Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance]Corentin S Lefebvre, Sophie Luneau, Nûn Kalim Bentounes, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
The First Autoregulated Total Artificial Heart Implant in the United StatesJacob N Schroder, Sharon L McCartney, Piet Jansen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 17, 2022
Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantationDavid M Smadja, Peter Ivak, Yuri Pya, et al.
Angiogenesis|December 20, 2024
Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19David M Smadja, Sven Günther, Pauline Cavagna, et al.
Leukemia|September 18, 2023
Correction: Human CD34<sup>+</sup> very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acidAlison Domingues, Elisa Rossi, Kamila Bujko, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 8, 2017
A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot studyChristian Latrémouille, Alain Carpentier, Pascal Leprince, et al.
Stem Cell Reviews and Reports|March 14, 2025
Circulating CD34<sup>+</sup> Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary EmbolismNicolas Gendron, Benjamin Planquette, Anne Roche, et al.
Oncoimmunology|December 21, 2020
No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, et al.
Leukemia|February 16, 2022
Human CD34<sup>+</sup> very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acidAlison Domingues, Elisa Rossi, Kamila Bujko, et al.
Angiogenesis|May 11, 2021
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalanceAurélien Philippe, Nicolas Gendron, Olivier Bory, et al.
Pageof 23